Related Experiment Videos
Automated cytogenetic analysis: accomplishments, present status and practical future possibilities
1Department of Obstetrics and Gynecology, Rigshospitalet, Copenhagen, Denmark.
Clinical Genetics
|November 1, 1989
Summary
Automated cytogenetic analysis systems have advanced significantly over 25 years. Early systems like Magiscan integrated into clinical labs, paving the way for continued development in chromosome analysis.
Area of Science:
- Medical technology
- Genetics
- Computational biology
Background:
- Significant research has focused on automated cytogenetic analysis systems over the past 25 years.
- Over 10 commercial systems are available, ranging from $50,000 to $200,000.
- The Magiscan chromosome system was the first to be implemented in a clinical setting.
Purpose of the Study:
- To review the development and implementation of automated cytogenetic analysis systems.
- To highlight the capabilities and usage of early automated systems in a clinical laboratory.
Main Methods:
- Analysis of data from 6752 cases using systems capable of metaphase finding and karyotyping.
- Production of 7036 karyotypes using a "karyotyping-only" system.
- Review of historical data on automated cytogenetic system performance.
Main Results:
- The Magiscan system was integrated into clinical practice at Rigshospitalet, Copenhagen.
- Extensive case analysis was performed using both integrated and karyotyping-only systems between 1983-1987.
- Commercial availability of multiple automated chromosome analysis systems indicates market adoption.
Conclusions:
- Automated cytogenetic analysis systems have evolved considerably.
- Early systems demonstrated clinical utility and paved the way for further advancements.
- Ongoing development aims to further enhance the performance of these critical diagnostic tools.